Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
6.38
-0.06 (-0.93%)
At close: Dec 5, 2025, 4:00 PM EST
6.44
+0.06 (0.94%)
After-hours: Dec 5, 2025, 7:53 PM EST
Aquestive Therapeutics Market Cap
Aquestive Therapeutics has a market cap or net worth of $778.38 million as of December 5, 2025. Its market cap has increased by 77.11% in one year.
Market Cap
778.38M
Enterprise Value
690.69M
1-Year Change
77.11%
Ranking
Category
Stock Price
$6.38
Market Cap Chart
Since July 25, 2018, Aquestive Therapeutics's market cap has increased from $393.23M to $778.38M, an increase of 97.95%. That is a compound annual growth rate of 9.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 778.38M | 139.80% |
| Dec 31, 2024 | 324.59M | 140.67% |
| Dec 29, 2023 | 134.87M | 176.07% |
| Dec 30, 2022 | 48.85M | -68.73% |
| Dec 31, 2021 | 156.24M | -13.14% |
| Dec 31, 2020 | 179.87M | -3.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |